Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Cash from Investing Activities (2020 - 2023)

BioAtla (BCAB) has 4 years of Cash from Investing Activities data on record, last reported at -$8000.0 in Q4 2023.

  • For Q4 2023, Cash from Investing Activities rose 74.19% year-over-year to -$8000.0; the TTM value through Sep 2024 reached -$8000.0, up 93.39%, while the annual FY2023 figure was -$98000.0, 63.02% up from the prior year.
  • Cash from Investing Activities reached -$8000.0 in Q4 2023 per BCAB's latest filing, up from -$25000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$8000.0 in Q4 2023 and bottomed at -$501000.0 in Q1 2021.
  • Average Cash from Investing Activities over 4 years is -$117312.5, with a median of -$62000.0 recorded in 2020.
  • Peak YoY movement for Cash from Investing Activities: tumbled 2405.0% in 2021, then surged 98.0% in 2022.
  • A 4-year view of Cash from Investing Activities shows it stood at -$395000.0 in 2020, then skyrocketed by 77.47% to -$89000.0 in 2021, then surged by 65.17% to -$31000.0 in 2022, then surged by 74.19% to -$8000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$8000.0 in Q4 2023, -$25000.0 in Q3 2023, and -$15000.0 in Q2 2023.